FIJYX
Price
$32.34
Change
+$0.10 (+0.31%)
Updated
Dec 24 closing price
JNGLX
Price
$68.85
Change
+$0.12 (+0.17%)
Updated
Dec 24 closing price
Ad is loading...

FIJYX vs JNGLX

Header iconFIJYX vs JNGLX Comparison
Open Charts FIJYX vs JNGLXBanner chart's image
Fidelity Advisor Biotechnology Z
Price$32.34
Change+$0.10 (+0.31%)
VolumeN/A
CapitalizationN/A
Janus Henderson Global Life Sciences D
Price$68.85
Change+$0.12 (+0.17%)
VolumeN/A
CapitalizationN/A
FIJYX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FIJYX vs. JNGLX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIJYX is a StrongBuy and JNGLX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5.25B vs. FIJYX (1.74B). FIJYX pays higher dividends than JNGLX: FIJYX (1.37) vs JNGLX (0.12). FIJYX was incepted earlier than JNGLX: FIJYX (6 years) vs JNGLX (26 years). FIJYX is a more actively managed with annual turnover of: 78.00 vs. JNGLX (34.00). FIJYX has a lower initial minimum investment than JNGLX: FIJYX (0) vs JNGLX (2500). FIJYX annual gain was more profitable for investors over the last year : 11.75 vs. JNGLX (1.63). JNGLX return over 5 years is better than : 14.30 vs. FIJYX (10.23).
FIJYXJNGLXFIJYX / JNGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years26 years-
Gain YTD7.754-0.253-3,062%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.74B5.25B33%
Annual Yield % from dividends1.370.121,154%
Returns for 1 year11.751.63722%
Returns for 3 years8.69-0.41-2,142%
Returns for 5 years10.2314.3072%
Returns for 10 yearsN/A35.67-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBFFX36.870.17
+0.46%
American Funds Global Balanced 529F1
STMMX35.420.10
+0.28%
Sterling Capital Real Estate A
BMSTX14.200.01
+0.07%
MFS Blended Research Mid Cap Eq R3
PCVCX9.83N/A
N/A
Virtus NFJ Small-Cap Value C
FFAAX15.83N/A
N/A
Franklin Global Allocation Adv